SCHEMBL17599335

SCHEMBL17599335

Cc1nc(-c2ccc(C(F)(F)F)cc2)sc1S(=O)(=O)Nc1ccc(-c2cccc(C(=O)O)c2F)c2ccccc12

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KEAP1 Q14145 1/20 0.47
▸ NR1H4 Q96RI1 1/20 0.42
▸ PPARA Q07869 6/20 0.41
▸ ACLY P53396 5/20 0.40
▸ GAA P10253 2/20 0.40
▸ PPARG P37231 2/20 0.40
▸ ALDH1A1 P00352 2/20 0.40
▸ KDM1A O60341 2/20 0.40
▸ MEN1 O00255 1/20 0.40
▸ KMT2A Q03164 1/20 0.40
▸ PPARD Q03181 1/20 0.40
▸ NPC1 O15118 1/20 0.40
▸ SMN1; SMN2 Q16637 1/20 0.38
▸ USP2 O75604 1/20 0.38
▸ USP8 P40818 1/20 0.38
▸ CA12 O43570 1/20 0.38
▸ CA1 P00915 1/20 0.38
▸ CA2 P00918 1/20 0.38
▸ CA5A P35218 1/20 0.38
▸ CA9 Q16790 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17599326 0.85 KEAP1 (0.46) KEAP1NR1H4PPARAACLYGAA
SCHEMBL17599390 0.76 KEAP1 (0.56) KEAP1NR1H4PPARAACLYALDH1A1
SCHEMBL17599372 0.72 ALDH1A1 (0.62) KEAP1ACLYGAAALDH1A1MEN1
SCHEMBL17599341 0.68 FABP4 (0.43) KEAP1ACLYALDH1A1KMT2ASMN1; SMN2
SCHEMBL17599309 0.68 NPC1 (0.52) NR1H4PPARAGAAPPARGALDH1A1
SCHEMBL17599343 0.68 KEAP1 (0.46) KEAP1ACLYKMT2A
SCHEMBL1093957 0.65 KDM1A (0.62) ACLYGAAALDH1A1KDM1AMEN1
SCHEMBL17599444 0.64 KEAP1 (1.00) KEAP1PPARAGAAPPARGPPARD
SCHEMBL17599331 0.64 PIK3CG (0.45) KEAP1KMT2A
SCHEMBL981341 0.64 SMN1; SMN2 (0.71) NR1H4PPARAGAAPPARGALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2998294-A1 Naphthyl sulfonamide phenyl derivatives as KEAP-1 modulators for the treatment of diabetes, obesity, dyslipidemia and related disorders SANOFI (FR) 2016-03-23 — — EP disclosed
EP-2998294-A1 Naphthyl sulfonamide phenyl derivatives as KEAP-1 modulators for the treatment of diabetes, obesity, dyslipidemia and related disorders SANOFI (FR) 2016-03-23 — — EP disclosed
Send feedback